INS and metabolic syndrome: The increased renal sodium reabsorption, the augmented hepatic very low-density lipoprotein synthesis, the hyperactivity of hydroxymethylglutaryl coenzyme A reductase, the increased platelet adhesion and aggregation activity, and the central obesity found in patients with metabolic syndrome and in type 2 diabetics can also be viewed as examples of augmented insulin action.